Online Food Delivery Platform Zomato Files For Rs 8,250 Crore IPO With SEBI swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
Info Edge to tell stake worth Rs 750 crore in Zomato IPO
Zomato, which started operations as a restaurant review and discovery platform, is planning to raise $650 million to $1 billion through the primary stake sale
BusinessToday.In | April 28, 2021 | Updated 02:08 IST
Info Edge board of directors have approved sale of the company s stake worth Rs 750 crore in Zomato during the latter s upcoming initial public offering (IPO). The parent company will offload the shares via offer for sale. Zomato Limited is proposing an IPO of its Equity Shares, comprising a fresh issue of Equity Shares by Zomato Limited and an Offer For Sale by Info Edge (India) Limited, Info Edge said in a regulatory filing on Tuesday.
Aditya Birla Sun Life AMC files DRHP for IPO
April 20, 2021
×
Aditya Birla Capital Ltd and Sun Life India will together sell up to 13.50% of the paid-up share capital of ABSL AMC via OFS
Aditya Birla Sun Life AMC, a material subsidiary of Aditya Birla Capital Limited, has filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offering by way of an offer-for-sale of shares.
Aditya Birla Capital has approved sale of up to 28,50,880 equity shares of face value ₹5 each held in ABSLAMC out of the total paid-up share capital of 28,80,00,000 equity shares.
Glenmark arm files IPO papers with SEBI
April 17, 2021
Plans to sell over 73 lakh shares via Offer For Sale
Glenmark Life Sciences Limited, a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, has filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer.
The company plans to raise ₹1,160 crore with an Offer For Sale of up to 7,305,245 equity shares of ₹2 each of Glenmark Life Sciences Limited. The board of directors of Glenmark Pharmaceuticals Limitedon Friday approved the OFS.
Glenmark Pharma holds 100 per cent stake in Glenmark Life Sciences, which is primarily into manufacturing and marketing of Active Pharmaceutical Ingredients (APIs). It has a product portfolio of more than 130 APIs and a catalogue of over 270 inventions. The firm, which supplies APIs to more than 700 customers across 65 countries, also develops 10-12 new products every year. Glenmark Life Sciences has manufacturing operations in Gujara
Glenmark Pharma arm files papers for IPO
PTI
New Delhi |
Updated on
April 17, 2021
×
Glenmark Life Sciences Ltd to make fresh issue of up to ₹1,160 crore and OFS of up to 73,05,245 equity shares of ₹2 each
Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed preliminary papers for an initial public offer (IPO) with market regulator SEBI. Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offer, said a regulatory filing. The offer comprises a fresh issue of up to ₹1,160 crore and an offer-for-sale (OFS) of up to 73,05,245 equity shares of ₹2 each of Glenmark Life Sciences Ltd, by Glenmark Pharmaceuticals Ltd, the filing said.